318 related articles for article (PubMed ID: 30130594)
1. Neuroprotective effect of naringin, a flavone glycoside in quinolinic acid-induced neurotoxicity: Possible role of PPAR-γ, Bax/Bcl-2, and caspase-3.
Cui J; Wang G; Kandhare AD; Mukherjee-Kandhare AA; Bodhankar SL
Food Chem Toxicol; 2018 Nov; 121():95-108. PubMed ID: 30130594
[TBL] [Abstract][Full Text] [Related]
2. Minocycline modulates neuroprotective effect of hesperidin against quinolinic acid induced Huntington's disease like symptoms in rats: behavioral, biochemical, cellular and histological evidences.
Kumar A; Chaudhary T; Mishra J
Eur J Pharmacol; 2013 Nov; 720(1-3):16-28. PubMed ID: 24211676
[TBL] [Abstract][Full Text] [Related]
3. Pioglitazone ameliorates behavioral, biochemical and cellular alterations in quinolinic acid induced neurotoxicity: possible role of peroxisome proliferator activated receptor-Upsilon (PPARUpsilon) in Huntington's disease.
Kalonia H; Kumar P; Kumar A
Pharmacol Biochem Behav; 2010 Aug; 96(2):115-24. PubMed ID: 20450929
[TBL] [Abstract][Full Text] [Related]
4. Protective effect of montelukast against quinolinic acid/malonic acid induced neurotoxicity: possible behavioral, biochemical, mitochondrial and tumor necrosis factor-α level alterations in rats.
Kalonia H; Kumar P; Kumar A; Nehru B
Neuroscience; 2010 Nov; 171(1):284-99. PubMed ID: 20813166
[TBL] [Abstract][Full Text] [Related]
5. Neuroprotective effects of roflumilast against quinolinic acid-induced rat model of Huntington's disease through inhibition of NF-κB mediated neuroinflammatory markers and activation of cAMP/CREB/BDNF signaling pathway.
Saroj P; Bansal Y; Singh R; Akhtar A; Sodhi RK; Bishnoi M; Sah SP; Kuhad A
Inflammopharmacology; 2021 Apr; 29(2):499-511. PubMed ID: 33517508
[TBL] [Abstract][Full Text] [Related]
6. L-theanine prevent quinolinic acid induced motor deficit and striatal neurotoxicity: Reduction in oxido-nitrosative stress and restoration of striatal neurotransmitters level.
Jamwal S; Singh S; Gill JS; Kumar P
Eur J Pharmacol; 2017 Sep; 811():171-179. PubMed ID: 28624333
[TBL] [Abstract][Full Text] [Related]
7. Improvement of mitochondrial NAD(+)/FAD(+)-linked state-3 respiration by caffeine attenuates quinolinic acid induced motor impairment in rats: implications in Huntington's disease.
Mishra J; Kumar A
Pharmacol Rep; 2014 Dec; 66(6):1148-55. PubMed ID: 25443748
[TBL] [Abstract][Full Text] [Related]
8. Protective Effect of Spermidine Against Excitotoxic Neuronal Death Induced by Quinolinic Acid in Rats: Possible Neurotransmitters and Neuroinflammatory Mechanism.
Jamwal S; Singh S; Kaur N; Kumar P
Neurotox Res; 2015 Aug; 28(2):171-84. PubMed ID: 26078029
[TBL] [Abstract][Full Text] [Related]
9. Naringin modulates oxidative stress and inflammation in 3-nitropropionic acid-induced neurodegeneration through the activation of nuclear factor-erythroid 2-related factor-2 signalling pathway.
Gopinath K; Sudhandiran G
Neuroscience; 2012 Dec; 227():134-43. PubMed ID: 22871521
[TBL] [Abstract][Full Text] [Related]
10. Role of Rho Kinase Inhibition in the Protective Effect of Fasudil and Simvastatin Against 3-Nitropropionic Acid-Induced Striatal Neurodegeneration and Mitochondrial Dysfunction in Rats.
Ahmed LA; Darwish HA; Abdelsalam RM; Amin HA
Mol Neurobiol; 2016 Aug; 53(6):3927-3938. PubMed ID: 26169112
[TBL] [Abstract][Full Text] [Related]
11. Rosiglitazone synergizes the neuroprotective effects of valproic acid against quinolinic acid-induced neurotoxicity in rats: targeting PPARγ and HDAC pathways.
Mishra J; Chaudhary T; Kumar A
Neurotox Res; 2014 Aug; 26(2):130-51. PubMed ID: 24566814
[TBL] [Abstract][Full Text] [Related]
12. Chrysin exerts neuroprotective effects against 3-Nitropropionic acid induced behavioral despair-Mitochondrial dysfunction and striatal apoptosis via upregulating Bcl-2 gene and downregulating Bax-Bad genes in male wistar rats.
Thangarajan S; Ramachandran S; Krishnamurthy P
Biomed Pharmacother; 2016 Dec; 84():514-525. PubMed ID: 27690136
[TBL] [Abstract][Full Text] [Related]
13. Sertraline and venlafaxine improves motor performance and neurobehavioral deficit in quinolinic acid induced Huntington's like symptoms in rats: Possible neurotransmitters modulation.
Gill JS; Jamwal S; Kumar P; Deshmukh R
Pharmacol Rep; 2017 Apr; 69(2):306-313. PubMed ID: 28178592
[TBL] [Abstract][Full Text] [Related]
14. Improvement of mitochondrial function by paliperidone attenuates quinolinic acid-induced behavioural and neurochemical alterations in rats: implications in Huntington's disease.
Mishra J; Kumar A
Neurotox Res; 2014 Nov; 26(4):363-81. PubMed ID: 24752928
[TBL] [Abstract][Full Text] [Related]
15. Role of LOX/COX pathways in 3-nitropropionic acid-induced Huntington's disease-like symptoms in rats: protective effect of licofelone.
Kumar P; Kalonia H; Kumar A
Br J Pharmacol; 2011 Sep; 164(2b):644-54. PubMed ID: 21486276
[TBL] [Abstract][Full Text] [Related]
16. Bilateral quinolinic acid-induced lipid peroxidation, decreased striatal monoamine levels and neurobehavioral deficits are ameliorated by GIP receptor agonist D-Ala
Verma MK; Goel R; Nandakumar K; Nemmani KVS
Eur J Pharmacol; 2018 Jun; 828():31-41. PubMed ID: 29577894
[TBL] [Abstract][Full Text] [Related]
17. Neuroprotective effect of MK-801 against intra-striatal quinolinic acid induced behavioral, oxidative stress and cellular alterations in rats.
Kalonia H; Kumar P; Nehru B; Kumar A
Indian J Exp Biol; 2009 Nov; 47(11):880-92. PubMed ID: 20099461
[TBL] [Abstract][Full Text] [Related]
18. Suppressing inflammatory cascade by cyclo-oxygenase inhibitors attenuates quinolinic acid induced Huntington's disease-like alterations in rats.
Kalonia H; Kumar A
Life Sci; 2011 Apr; 88(17-18):784-91. PubMed ID: 21362433
[TBL] [Abstract][Full Text] [Related]
19. Protective effect of hesperidin and naringin against 3-nitropropionic acid induced Huntington's like symptoms in rats: possible role of nitric oxide.
Kumar P; Kumar A
Behav Brain Res; 2010 Jan; 206(1):38-46. PubMed ID: 19716383
[TBL] [Abstract][Full Text] [Related]
20. Neuroprotective efficacy of naringin on 3-nitropropionic acid-induced mitochondrial dysfunction through the modulation of Nrf2 signaling pathway in PC12 cells.
Kulasekaran G; Ganapasam S
Mol Cell Biochem; 2015 Nov; 409(1-2):199-211. PubMed ID: 26280522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
